Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Spero Therapeutics
Spero Therapeutics
Spero’s stock slides after antibiotic flops in Phase II trial
Clinical Trials Arena
Wed, 10/30/24 - 11:44 am
Spero Therapeutics
SPR720
non-tuberculous mycobacteria pulmonary disease
clinical trials
GSK plays the white knight, paying $66M to rescue Spero's oral antibiotic after FDA rejection
Fierce Biotech
Thu, 09/22/22 - 10:54 am
GSK
Spero Therapeutics
antibiotics
tebipenem
Why Spero Therapeutics Stock Is Up 15% Today
Motley Fool
Thu, 07/1/21 - 10:32 pm
Spero Therapeutics
Pfizer
SPR206
multi-drug resistant infections
Biotech IPOs: Intra-Cellular Therapies, 10x Genomics and Spero Therapeutics
BioSpace
Sat, 09/12/20 - 10:15 pm
biotech
IPOs
Intra-Cellular Therapies
10x Genomics
Spero Therapeutics
Spero Therapeutics and the Gates Foundation Collaborate on Tuberculosis Treatment
BioSpace
Thu, 06/20/19 - 07:52 pm
Spero Therapeutics
Gates Foundation
tuberculosis
drug development